-
University, Companies to Build Medical Analytics Platform
University of Pittsburgh Medical Center, with four corporate technology partners, will build a comprehensive medical analytics database, integrating data from 200+ diverse research, clinical, and business sources. The two-year project is expected to cost $100 million and include the companies Oracle, IBM, Informatica, and dbMotion. Financial details of the corporate contributions were not disclosed. The…
-
Smartphones Found Feasible Tools for Telemedicine Images
Researchers at the Mayo Clinic in Phoenix and clinician colleagues in Arizona found smartphones could exchange acceptable teleradiology images for stroke diagnosis under real-world conditions. The findings from this clinical trial appear online in the journal Stroke. The research, led by Mayo Clinic neurologist Bart Demaerschalk, tested the smartphone application ResolutionMD used to transmit CT…
-
Artificial Kidney Project Lands New $750,000 Funding
The Kidney Project, an academic-corporate initiative led by University of California in San Francisco to develop an implantable device to replace failed kidneys, secured a new $750,000 grant from the John and Marcia Goldman Foundation. The funding supplements a $2.25 million grant received this summer from National Institutes of Health (NIH). The artificial kidney aims…
-
Ninety Minute Forensic DNA Test System Now Available
IntegenX Inc. in Pleasanton, California, a developer of human DNA identification technology, says its RapidHIT 200 system for DNA testing in criminal investigations is now on the market. The system, which the company says can produce a standard DNA profile in about 90 minutes, is being demonstrated at the International Association of Chiefs of Police…
-
New Artificial Corneas Advance to Animal Testing
Researchers at the Fraunhofer Institute for Applied Polymer Research in Potsdam, Germany are developing new artificial corneas that can treat a wider range of eye conditions than current devices. The team led by Fraunhofer’s Joachim Storsberg (pictured left) is collaborating with the Aachen Centre of Technology Transfer, Martin Luther University of Halle-Wittenberg, and the Cologne-Merheim Ophthalmic…
-
Optical Semiconductor Etching/Monitoring Process Devised
Engineers at University of Illinois in Urbana created an etching and sculpting process for semiconductors using light that also monitors the etching process in real time. The team led by Illinois electrical and computer engineering professors Gabriel Popescu and Lynford Goddard published its findings today in the journal Light Science and Applications. Chip makers need…
-
Luminous Nanoparticles Detectable Through Tissue Developed
Researchers in the U.S., Sweden, China, and Korea created illuminated nanoscale particles that can be detected through a 3.2 centimeter, or 1.26 inch layer of tissue. The team led by University at Buffalo, New York chemistry professor Paras Prasad and University of Massachusetts medical professor Gang Han published its findings last month in the journal…
-
Contract Awarded for Stem Cell Derived Burn Therapy
Cytori Therapeutics in San Diego received a contract from Biomedical Advanced Research and Development Authority (BARDA) for development of a cell therapy to treat thermal burns combined with radiation injury. The contract from BARDA, an agency of the U.S. Department of Health and Human Services, has a value of up to $106 million over a…
-
FDA Approves Colorectal Cancer Treatment
The U.S. Food and Drug Administration approved the drug regorafenib to treat patients with metastatic colorectal cancer, where the cancer has progressed after treatment and spread to other parts of the body. Regorafenib is marketed under the brand name Stivarga by Bayer HealthCare Pharmaceuticals, in Wayne, New Jersey. Stivarga blocks several enzymes that promote cancer…
-
European Approval Granted for Breast Cancer Gene Test
NanoString Technologies Inc. in Seattle, a developer of genetic medical diagnostics, received a CE mark noting regulatory approval in Europe for its PAM50-based gene expression test for breast cancer. The CE mark, an acronym for the French Conformité Européene, indicates a product meets safety, health, and environmental protection requirements in the 27 EU member states,…